Aperam (APEMY)
(Delayed Data from OTC)
$27.31 USD
+1.91 (7.52%)
Updated Jul 10, 2024 02:36 PM ET
3-Hold of 5 3
A Value C Growth F Momentum B VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
APEMY 27.31 +1.91(7.52%)
Will APEMY be a Portfolio Killer in July?
Zacks Investment Research is releasing its prediction for APEMY based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for APEMY
Is Aperam (APEMY) Stock Undervalued Right Now?
All You Need to Know About Aperam (APEMY) Rating Upgrade to Strong Buy
APEMY: What are Zacks experts saying now?
Zacks Private Portfolio Services
Should Value Investors Buy Aperam (APEMY) Stock?
Aperam (APEMY) Flat As Market Sinks: What You Should Know
Are Basic Materials Stocks Lagging Aperam (APEMY) This Year?
Other News for APEMY
Aperam price target raised by EUR 1 at Morgan Stanley
Horos Asset Management Quarterly Letter To Our Co-Investors - May 2024
Aperam price target lowered by EUR 1 at Barclays
Aperam price target lowered by EUR 0.30 at JPMorgan
Aperam price target lowered by EUR 1 at Barclays